Cellectis' IPO

Cellectis raised a round of funding on March 25, 2015. Investors include Public.

Cellectis is a gene-editing company, employing proprietary technologies to develop best-in-class products in the emerging field of immuno-oncology. The company's product candidates, based on gene-edit…

Articles about Cellectis' IPO: